About
Immune System Rebalancing using Semi-Apoptotic Cells
Areas of Focus
Categories
Stem Cell & Cellular TherapyMiddle East
Clinical Trials (9)
View allTotal Trials
9
As Lead Sponsor
8
As Collaborator
1
Total Enrollment
395
By Phase
PHASE1: 3PHASE1/PHASE2: 3EARLY_PHASE1: 1PHASE2: 2
By Status
TERMINATED: 3ACTIVE_NOT_RECRUITING: 2COMPLETED: 2RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06522035Lead Sponsor
Evaluation of Allocetra by Intra-articular Injection for the Treatment of Psoriatic Arthritis
PHASE1Recruiting
6 participants
Started: Aug 1, 2024 · Completed: Sep 30, 2026
NCT06233474Lead Sponsor
Study of Intra-articular Allocetra in Knee Osteoarthritis
PHASE1/PHASE2Active, not recruiting
160 participants
Started: Jan 26, 2024 · Completed: Feb 1, 2026
NCT06208241Collaborator
Use of Allocetra-OTS in End Stage Knee Osteoarthritis - Assessment of Safety
EARLY_PHASE1Active, not recruiting
18 participants
Started: Jul 12, 2023 · Completed: Dec 30, 2025
NCT05581719Lead Sponsor
A Phase 1/2a Study Evaluating Allocetra-OTS as Monotherapy or in Combination With Anti-PD-1 Therapy for the Treatment of Advanced Solid Tumor Malignancy
PHASE1/PHASE2Terminated
14 participants
Started: Nov 15, 2022 · Completed: Apr 15, 2024
NCT05431907Lead Sponsor
Phase 1/2 Study Evaluating Safety and Potential Efficacy of Allocetra-OTS Via Pressurized Intra-Peritoneal Aerosol Chemotherapy as Add-on to Standard of Care Chemotherapy for Treatment of Peritoneal Metastasis
PHASE1/PHASE2Terminated
9 participants
Started: Jun 29, 2022 · Completed: Mar 14, 2024
Locations (1)
Headquarters
Ness Ziona, Israel
Map
Loading map...